Molecule of the month. Bifeprunox mesilate.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001583:Benzoxazoles / Q000633:toxicity*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D010879:Piperazines / Q000633:toxicity*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001583:Benzoxazoles; D010879:Piperazines; C509981:bifeprunox